Clinical trial tech Valis is a specialized provider of 21 CFR Part 11 compliant video recording and eCOA technologies with expertise in psychiatry and neurology clinical trials, presenting a cross-sell opportunity for integrated trial monitoring, data capture, and central review services.

Psychedelic therapy focus Their work in psychedelic compounds for PTSD and other conditions signals potential demand for secure, compliant digital data capture and analysis tools tailored to dissociative and psychedelic drug development programs across rare and orphan diseases.

Rater training edge Valis offers exclusive licensed PANSS training and a suite of psychometric and protocol development services, enabling partnerships to externalize training, rater certification, and scale validation for multicenter psychiatric trials.

Integrated services With offerings spanning scientific consulting, data validation, scale licensing, ML-backed transcription, and LMS solutions, Valis can be positioned as a one-stop shop for end-to-end trial data integrity, patient-reported outcomes, and clinician assessments.

Growth indicators Revenue in the range of 10 to 25 million with a lean team (11-50 employees) suggests agility and potential for scalable partnerships with larger CROs or pharma firms seeking specialized, compliant trial data and video review capabilities.